Macular Society
National Tariff Consultation June 2018 – RCOphth, RNIB, IGA and Macular Society collaborate on response
In preparation for the National Tariff Consultation due to be released shortly, The Royal College of Ophthalmologists and patient organisations; Royal National Institute of Blind People (RNIB), International Glaucoma Association (IGA) and the Macular Society, have collaborated on key messages that will be used in response to the consultation. This group have written to NHS Improvement
Macular Society’s call for more funding of research into macular degeneration
Statement from the Macular Society Charity’s landmark report exposing lack of investment in age-related macular degeneration (AMD) is supported by more than 60 of the UK’s foremost sight researchers, ophthalmologists and institutions – Situation described as ‘urgent’ It is a disease with devastating and far-reaching consequences for both patients and their families, and the number of
New patient self-advocacy project
The RNIB (Royal National Institute of Blind People) launched this joint initiative with The Royal College of Ophthalmologists, Macular Society and International Glaucoma Association at RCOphth’s Congress on 24 May 2016 in Birmingham. The initiative fits with the RCOphth’s Three Step Plan ‘Reducing risk for eye patients – improving timely care’. The plan outlines solutions to
Survey finds nearly 70% of patients waiting too long for treatment
A survey of ophthalmologists found that nearly 70% of patients with wet age-related macular degeneration (AMD) had to wait more than the recommended two weeks for their first sight-saving injection. Many also wait too long for follow up treatment. The Royal College of Ophthalmologists and the Macular Society say their research shows that more resources
Survey results show under resourced eye clinics put patients’ sight at risk
Press Release UK survey by the Macular Society and the Royal College of Ophthalmologists highlights concerns over eye clinic capacity Thousands of elderly people with eye disease are receiving poor or very poor NHS services according to a survey of hospital ophthalmologists. The survey, by the Macular Society and the Royal College of Ophthalmologists, asked